After reading the article again, you have a good point. Not sure if it was intended as a hit job, but they did include some criticism in the article along with the positives:

Quote:

---

After two years, CytoDyn’s HIV program is "finally" free of the FDA clinical hold.

Earlier this month, CytoDyn "finally" submitted a revised protocol for the HIV trial

---